ArticleTherapeutic advances in neurological disorders2023

Evaluation of frequency, severity, and independent risk factors for recurrence of disease activity after fingolimod discontinuation in a large real-world cohort of patients with multiple sclerosis.

Nuria Cerdá-Fuertes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.